9 matches for your search in the start-up spotlight
rss
KA-EX® is a patented food supplement consisting of scientifically selected macro- and micronutrients. The powdered drink is mixed with 300ml - 500ml of water and taken after intense sports or alcohol consumption. The clinically tested substances protect the body from toxic damage, preventing ...
At Koa, we redefine the perception of value creation in the cocoa value chain of rural West Africa. By utilising the so far discarded cocoa pulp, we increase farmer's income and reduce food waste. The new technology is carbon neutral and solar-powered. Thanks to the decentral extraction, we can ...
Battronics provides knowledge, consulting and research for Li-ion batteries and their electronics and management system.
The Swiss start-up company Juvabis designs next-generation aminoglycoside antibiotics that withstand mechanisms of bacterial drug-resistance and at the same time display superior tolerability due to increased target selectivity by rational design. Juvabis has been founded around a proprietary ...
DataHow AG is a spin-off company from ETH Zurich specialized in data analytics and process modeling for the process industry with a particular focus on the biopharmaceutical and chemical domains. We offer digital solutions and consulting for process screening, monitoring, optimization, control ...
LARI helps businesses keep track of legal and regulatory changes. Our mission is to promote collaboration and increase workflow productivity of corporate legal departments. LARI is an intelligent issue management platform for legal and compliance departments. It automatically discovers the ...
LARI helps businesses keep track of legal and regulatory changes. Our mission is to promote collaboration and increase workflow productivity of corporate legal departments. LARI is an intelligent issue management platform for legal and compliance departments. It automatically discovers the ...
TOLREMO therapeutics AG ("TOLREMO") is a Swiss biotechnology company that was spun out of ETH Zurich in 2017. Based on cutting-edge science and guided by pioneering real-world medicine, TOLREMO created a broad cancer drug resistance platform that provides a unique entry point into a major ...
